271 related articles for article (PubMed ID: 28807905)
1. Pulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in Rats.
Lin YW; Zhou QT; Hu Y; Onufrak NJ; Sun S; Wang J; Forrest A; Chan HK; Li J
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807905
[TBL] [Abstract][Full Text] [Related]
2. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. Colistin.
Gontijo AV; Grégoire N; Lamarche I; Gobin P; Couet W; Marchand S
Antimicrob Agents Chemother; 2014 Jul; 58(7):3950-6. PubMed ID: 24798284
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
Lin YW; Zhou QT; Cheah SE; Zhao J; Chen K; Wang J; Chan HK; Li J
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
[TBL] [Abstract][Full Text] [Related]
4. Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
Lin YW; Zhou Q; Onufrak NJ; Wirth V; Chen K; Wang J; Forrest A; Chan HK; Li J
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559256
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of nebulized colistin methanesulfonate in critically ill patients.
Boisson M; Grégoire N; Cormier M; Gobin P; Marchand S; Couet W; Mimoz O
J Antimicrob Chemother; 2017 Sep; 72(9):2607-2612. PubMed ID: 28575278
[TBL] [Abstract][Full Text] [Related]
6. Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model.
Landersdorfer CB; Nguyen TH; Lieu LT; Nguyen G; Bischof RJ; Meeusen EN; Li J; Nation RL; McIntosh MP
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821445
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of colistin methanesulfonate in rats: achieving sustained lung concentrations of colistin for targeting respiratory infections.
Yapa SWS; Li J; Porter CJ; Nation RL; Patel K; McIntosh MP
Antimicrob Agents Chemother; 2013 Oct; 57(10):5087-95. PubMed ID: 23917323
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs.
Kukut Hatipoglu M; Hickey AJ; Garcia-Contreras L
Int J Pharm; 2018 Oct; 549(1-2):306-316. PubMed ID: 30077761
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Aerosolized Colistin in a Mouse Lung Infection Model.
Lin YW; Zhou QT; Han ML; Onufrak NJ; Chen K; Wang J; Forrest A; Chan HK; Li J
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263069
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary selectivity and local pharmacokinetics of ambroxol hydrochloride dry powder inhalation in rat.
Ren YC; Wang L; He HB; Tang X
J Pharm Sci; 2009 May; 98(5):1797-803. PubMed ID: 18837427
[TBL] [Abstract][Full Text] [Related]
11. Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.
Boisson M; Jacobs M; Grégoire N; Gobin P; Marchand S; Couet W; Mimoz O
Antimicrob Agents Chemother; 2014 Dec; 58(12):7331-9. PubMed ID: 25267660
[TBL] [Abstract][Full Text] [Related]
12. Dry powder inhalation of colistin sulphomethate in healthy volunteers: A pilot study.
Westerman EM; de Boer AH; Le Brun PPH; Touw DJ; Frijlink HW; Heijerman HGM
Int J Pharm; 2007 Apr; 335(1-2):41-45. PubMed ID: 17178200
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.
Yapa SWS; Li J; Patel K; Wilson JW; Dooley MJ; George J; Clark D; Poole S; Williams E; Porter CJ; Nation RL; McIntosh MP
Antimicrob Agents Chemother; 2014 May; 58(5):2570-9. PubMed ID: 24550334
[TBL] [Abstract][Full Text] [Related]
14. Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients.
Le Brun PP; de Boer AH; Mannes GP; de Fraîture DM; Brimicombe RW; Touw DJ; Vinks AA; Frijlink HW; Heijerman HG
Eur J Pharm Biopharm; 2002 Jul; 54(1):25-32. PubMed ID: 12084499
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary pharmacokinetics of levofloxacin in rats after aerosolization of immediate-release chitosan or sustained-release PLGA microspheres.
Gaspar MC; Grégoire N; Sousa JJ; Pais AA; Lamarche I; Gobin P; Olivier JC; Marchand S; Couet W
Eur J Pharm Sci; 2016 Oct; 93():184-91. PubMed ID: 27531420
[TBL] [Abstract][Full Text] [Related]
16. Aerosol therapy with colistin methanesulfonate: a biopharmaceutical issue illustrated in rats.
Marchand S; Gobin P; Brillault J; Baptista S; Adier C; Olivier JC; Mimoz O; Couet W
Antimicrob Agents Chemother; 2010 Sep; 54(9):3702-7. PubMed ID: 20547787
[TBL] [Abstract][Full Text] [Related]
17. Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot study.
Westerman EM; De Boer AH; Le Brun PP; Touw DJ; Roldaan AC; Frijlink HW; Heijerman HG
J Cyst Fibros; 2007 Jul; 6(4):284-92. PubMed ID: 17185047
[TBL] [Abstract][Full Text] [Related]
18. Optimization of inhalable liposomal powder formulations and evaluation of their in vitro drug delivery behavior in Calu-3 human lung epithelial cells.
Yu S; Yuan H; Chai G; Peng K; Zou P; Li X; Li J; Zhou F; Chan HK; Zhou QT
Int J Pharm; 2020 Aug; 586():119570. PubMed ID: 32593649
[TBL] [Abstract][Full Text] [Related]
19. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Morimoto K
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary and Systemic Pharmacokinetics of Colistin Following a Single Dose of Nebulized Colistimethate in Mechanically Ventilated Neonates.
Nakwan N; Lertpichaluk P; Chokephaibulkit K; Villani P; Regazzi M; Imberti R
Pediatr Infect Dis J; 2015 Sep; 34(9):961-3. PubMed ID: 26065861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
